Middle-East and Africa Precision Medicine Market by Technology (Big Data Analytics, Bioinformatics, Gene Sequencing, Drug Discovery, Companion Diagnostics, Others), by Application (Oncology, CNS, Immunology, Respiratory, Others) and by Region - Industry Analysis, Size, Share, Growth, Trends, and Forecasts (2016–2021)

Middle-East and Africa Precision Medicine Market by Technology (Big Data Analytics, Bioinformatics, Gene Sequencing, Drug Discovery, Companion Diagnostics, Others), by Application (Oncology, CNS, Immunology, Respiratory, Others) and by Region - Industry Analysis, Size, Share, Growth, Trends, and Forecasts (2016–2021)

ID: 1480 | Pages: 130 | November 2016 | Region: Middle East and Africa


The Middle-East and Africa Precision Medicine market has been estimated at USD 3.24 Billion in 2016 and is projected to reach USD 5.54 Billion by 2021, at a CAGR of 11.32% during the forecast period from 2016 to 2021. Precision Medicine refers to the tailoring of medical treatment to the individual characteristics of each patient. Preventive or therapeutic interventions can then be concentrated on those who will benefit, sparing expense and side effects for those who will not.

The market for Precision Medicine is mainly driven due to increasing demand for personalized treatment, technological innovation and advancements and increased global incidence of cancer and rise in cancer susceptible aging population. But, the market growth can be restrained due to governmental regulations and standards, and decline in FDA drug approval rates.

Middle-East and Africa market for Precision Medicine is segmented based on Technology and Application. By Technology, the market is further sub-segmented into Big Data Analytics, Bioinformatics, Gene Sequencing, Drug Discovery, Companion Diagnostics and Others. By Application, the market is further sub-segmented into Oncology, CNS, Immunology, Respiratory and Others. By Application, oncology segment holds the largest market share, followed by the CNS and immunology segments. By Technology, drug discovery market holds the largest share, followed by gene sequencing and companion diagnostics. Big data analytics is expected to grow at the highest CAGR.

Geographically, Middle-East and Africa market for Precision Medicine is segmented into Middle-East region and Africa region. The market in this region is proceeding with high CAGR. Drug manufacturing and diagnostics companies are making promising efforts in improving industry scenario, which is providing opportunities in the untapped areas of this region.

Pfizer, Roche, Covance, Novartis, Qiagen, Biocrates Life Sciences, Teva Pharmaceutical, Nanostring Technologies, Laboratory Corporation of America Holdings, Tepnel Pharma Services, Intomics, Ferrer InCode, Silicon Biosystems, Eagle Genomics, Medtronic, and Quest Diagnostics, are the major players of Middle-East and Africa Precision Medicine market.

The Middle-East and Africa Precision Medicine market has been estimated at USD 3.24 Billion in 2016 and is projected to reach USD 5.54 Billion by 2021, at a CAGR of 11.32% during the forecast period from 2016 to 2021. Precision Medicine refers to the tailoring of medical treatment to the individual characteristics of each patient. Preventive or therapeutic interventions can then be concentrated on those who will benefit, sparing expense and side effects for those who will not.

The market for Precision Medicine is mainly driven due to increasing demand for personalized treatment, technological innovation and advancements and increased global incidence of cancer and rise in cancer susceptible aging population. But, the market growth can be restrained due to governmental regulations and standards, and decline in FDA drug approval rates.

Middle-East and Africa market for Precision Medicine is segmented based on Technology and Application. By Technology, the market is further sub-segmented into Big Data Analytics, Bioinformatics, Gene Sequencing, Drug Discovery, Companion Diagnostics and Others. By Application, the market is further sub-segmented into Oncology, CNS, Immunology, Respiratory and Others. By Application, oncology segment holds the largest market share, followed by the CNS and immunology segments. By Technology, drug discovery market holds the largest share, followed by gene sequencing and companion diagnostics. Big data analytics is expected to grow at the highest CAGR.

Geographically, Middle-East and Africa market for Precision Medicine is segmented into Middle-East region and Africa region. The market in this region is proceeding with high CAGR. Drug manufacturing and diagnostics companies are making promising efforts in improving industry scenario, which is providing opportunities in the untapped areas of this region.

Pfizer, Roche, Covance, Novartis, Qiagen, Biocrates Life Sciences, Teva Pharmaceutical, Nanostring Technologies, Laboratory Corporation of America Holdings, Tepnel Pharma Services, Intomics, Ferrer InCode, Silicon Biosystems, Eagle Genomics, Medtronic, and Quest Diagnostics, are the major players of Middle-East and Africa Precision Medicine market.

1.Introduction                                  

                1.1 Market Definition                    

                1.2 Study Deliverables                  

                1.3 Base Currency, Base Year and Forecast Periods                           

                1.4 General Study Assumptions                

2. Research Methodology                                           

                2.1 Introduction                              

                2.2 Research Phases                      

                                2.2.1 Secondary Research            

                                2.2.2 Primary Research 

                                2.2.3 Econometric Modelling     

                                2.2.4 Expert Validation  

                2.3 Analysis Design                         

                2.4 Study Timeline                          

3. Overview                                      

                3.1 Executive Summary                

                3.2 Key Inferences                         

                3.3 Epidemology                             

4. Drivers, Restraints, Opportunities, and Challenges Analysis (DROC)                                      

                4.1 Market Drivers                          

                4.2 Market Restraints                    

                4.3 Key Challenges                         

                4.4 Current Opportunities in the Market               

5. Market Segmentation                                              

                5.1 Technology                

                                5.1.1 Introduction           

                                5.1.2 Big Data Analytics

                                5.1.3 Bioinformatics       

                                5.1.4 Gene Sequencing

                                5.1.5 Drug Discovery      

                                5.1.6 Companion Diagnostics     

                                5.1.7 Others      

                                5.1.8 Y-o-Y Growth Analysis, By Technology         

                                5.1.9 Market Attractiveness Analysis, By Technology       

                                5.1.10 Market Share Analysis, By Technology      

                5.2 Application                 

                                5.2.1 Introduction           

                                5.2.2 Oncology 

                                5.2.3 CNS            

                                5.2.4 Immunology          

                                5.2.5 Respiratory             

                                5.2.6 Others      

                                5.2.7 Y-o-Y Growth Analysis, By Application         

                                5.2.8 Market Attractiveness Analysis, By Application        

                                5.2.9 Market Share Analysis, By Application         

6. Geographical Analysis                                              

                6.1 Introduction                              

                                6.1.1 Regional Trends    

                                6.1.2 Impact Analysis     

                                6.1.3 Y-o-Y Growth Analysis        

                                                6.1.3.1 By Geographical Area

                                                6.1.3.2 By Product

                                                6.1.3.3 By Type

                                                6.1.3.4 By Application

                                                6.1.3.5 By Indication

                                6.1.4 Market Attractiveness Analysis      

                                                6.1.4.1 By Geographical Area

                                                6.1.4.2 By Product

                                                6.1.4.3 By Type

                                                6.1.4.4 By Application

                                                6.1.4.5 By Indication

                                6.1.5 Market Share Analysis        

                                                6.1.5.1 By Geographical Area

                                                6.1.5.2 By Product

                                                6.1.5.3 By Type

                                                6.1.5.4 By Application

                                                6.1.5.5 By Indication

                6.2 Middle-East                                

                6.3 Africa                            

7.Strategic Analysis                                        

                7.1 PESTLE analysis                         

                                7.1.1 Political     

                                7.1.2 Economic 

                                7.1.3 Social         

                                7.1.4 Technological         

                                7.1.5 Legal          

                                7.1.6 Environmental      

                7.2 Porter’s Five analysis                              

                                7.2.1 Bargaining Power of Suppliers        

                                7.2.2 Bargaining Power of Consumers    

                                7.2.3 Threat of New Entrants     

                                7.2.4 Threat of Substitute Products and Services

                                7.2.5 Competitive Rivalry within the Industry      

8.Market Leaders' Analysis                                          

                8.1 Pfizer                            

                                8.1.1 Overview

                                8.1.2 Product Analysis   

                                8.1.3 Financial analysis  

                                8.1.4 Recent Developments       

                                8.1.5 SWOT analysis       

                                8.1.6 Analyst View          

                8.2 Roche                           

                8.3 Covance                      

                8.4 Novartis                       

                8.5 Qiagen                         

                8.6 Biocrates Life Sciences                          

                8.7 Teva Pharmaceutical                              

                8.8 Nanostring Technologies                      

                8.9 Laboratory Corporation of America Holdings                

                8.10 Medtronic                

9.Competitive Landscape                                            

                9.1 Market share analysis                            

                9.2 Merger and Acquisition Analysis                        

                9.3 Agreements, collaborations and Joint Ventures                          

                9.4 New Product Launches                          

10.Market Outlook and Investment Opportunities                                           

Appendix                                           

                a) List of Tables                

                b) List of Figures                              

  • Regional and country-level analysis and forecasts of the study market; providing Insights on the major countries/regions in which this industry is blooming and to also identify the regions that are still untapped
  • Segment-level analysis in terms of technology, component, and type along with market size forecasts and estimations to detect key areas of industry growth in detail
  • Identification of key drivers, restraints, opportunities, and challenges (DROC) in the market and their impact on shifting market dynamics
  • Study of the effect of exogenous and endogenous factors that affect the global market; which includes broadly demographic, economics, and political, among other macro-environmental factors presented in an extensive PESTLE Analysis
  • Study the micro environment factors that determine the overall profitability of an Industry, using Porter’s five forces analysis for analysing the level of competition and business strategy development
  • A comprehensive list of key market players along with their product portfolio, current strategic interests, key financial information, legal issues, SWOT analysis and analyst overview to study and sustain the market environment
  • Competitive landscape analysis listing out the mergers, acquisitions, collaborations in the field along with new product launches, comparative financial studies and recent developments in the market by the major companies
  • An executive summary, abridging the entire report in such a way that decision-making personnel can rapidly become acquainted with background information, concise analysis and main conclusions
  • Expertly devised analyst overview along with Investment opportunities to provide both individuals and organizations a strong financial foothold in the market
TitlePriceAdd To Cart
  1. Middle East & Africa Precision Medicine Market By Region, From 2016-2021 (USD Billion)
  2. Middle East & Africa Precision Medicine Market By Technology, From 2016-2021 (USD Billion)
  3. Middle East & Africa Big Data Analytics Market By Region, From 2016-2021 (USD Billion)
  4. Middle East & Africa Bioinformatics Market By Region, From 2016-2021 (USD Billion)
  5. Middle East & Africa Gene Sequencing Market By Region, From 2016-2021 (USD Billion)
  6. Middle East & Africa Drug Discovery Market By Region, From 2016-2021 (USD Billion)
  7. Middle East & Africa Companion Diagnostics Market By Region, From 2016-2021 (USD Billion)
  8. Middle East & Africa Other Precision Medicine Technologies Market By Region, From 2016-2021 (USD Billion)
  9. Middle East & Africa Precision Medicine Market By Application, From 2016-2021 (USD Billion)
  10. Middle East & Africa Oncology Precision Medicine Market By Region, From 2016-2021 (USD Billion)
  11. Middle East & Africa CNS Precision Medicine Market By Region, From 2016-2021 (USD Billion)
  12. Middle East & Africa Immunology Precision Medicine Market By Region, From 2016-2021 (USD Billion)
  13. Middle East & Africa Respiratory Precision Medicine Market By Region, From 2016-2021 (USD Billion)
  14. Middle East & Africa Other Precision Medicine Applications Market By Region, From 2016-2021 (USD Billion)
  15. Middle East Precision Medicine Market By Technology, From 2016-2021 (USD Billion)
  16. Middle East Precision Medicine Market By Application, From 2016-2021 (USD Billion)
  17. Africa Precision Medicine Market By Technology, From 2016-2021 (USD Billion)
  18. Africa Precision Medicine Market By Application, From 2016-2021 (USD Billion)
Middle East and Africa Antacid Market by Submarkets (Chromatography, E-Clinical Trial Solutions, Wireless Health, Clinical Trial Management Systems(CTMS), Healthcare IT outsourcing, Immunoassay, Digital Pathology, N...
Latin America Antacid Market by Submarkets (Chromatography, E-Clinical Trial Solutions, Wireless Health, Clinical Trial Management Systems(CTMS), Healthcare IT outsourcing, Immunoassay, Digital Pathology, Next Gener...
Asia-Pacific Antacid Market by Submarkets (Chromatography, E-Clinical Trial Solutions, Wireless Health, Clinical Trial Management Systems(CTMS), Healthcare IT outsourcing, Immunoassay, Digital Pathology, Next Genera...
Europe Antacid Market by Submarkets (Chromatography, E-Clinical Trial Solutions, Wireless Health, Clinical Trial Management Systems(CTMS), Healthcare IT outsourcing, Immunoassay, Digital Pathology, Next Generation s...
North America Antacid Market by Submarkets (Chromatography, E-Clinical Trial Solutions, Wireless Health, Clinical Trial Management Systems (CTMS), Healthcare IT outsourcing, Immunoassay, Digital Pathology, Next Gene...
Antacid Market by Submarkets (Chromatography, E-Clinical Trial Solutions, Wireless Health, Clinical Trial Management Systems(CTMS), Healthcare IT outsourcing, Immunoassay, Digital Pathology, Next Generation sequenci...
Middle East and Africa Generic Drugs Market by type (Biosimilars, simple generic and super generic) by therapeutic drugs (Cardiovascular products, anti-infective products, anti-arthritis drugs, central nervous syste...
Latin America Generic Drugs Market by type (Biosimilars, simple generic and super generic) by therapeutic drugs (Cardiovascular products, anti-infective products, anti-arthritis drugs, central nervous system drugs, ...
Asia-Pacific Generic Drugs Market by type (Biosimilars, simple generic and super generic) by therapeutic drugs (Cardiovascular products, anti-infective products, anti-arthritis drugs, central nervous system drugs, a...
Europe Generic Drugs Market by type (Biosimilars, simple generic and super generic) by therapeutic drugs (Cardiovascular products, anti-infective products, anti-arthritis drugs, central nervous system drugs, anti-ca...
North America Generic Drugs Market by type (Biosimilars, simple generic and super generic) by therapeutic drugs (Cardiovascular products, anti-infective products, anti-arthritis drugs, central nervous system drugs, ...
Generic Drugs Market by type (Biosimilars, simple generic and super generic) by therapeutic drugs (Cardiovascular products, anti-infective products, anti-arthritis drugs, central nervous system drugs, anti-cancer dr...

"We Think Through Different Layers, We Work Across Different Verticals."

Market Data Forecast, Inc.
502, Kakatiya's Empire,
Jubilee Gardens, Hyderabad,
Telangana, India.
+1-888-702-9626 (U.S. TOLL FREE)
contact@marketdataforecast.com


Subscribe To Our News Letter

Or follow us on social platform

© 2017 Market Data Forecast
All Rights Reserved.